The subtype-selective nicotinic acetylcholine receptor positive allosteric potentiator 2087101 differentially facilitates neurotransmission in the brain

European Journal of Pharmacology

Volumn 643, Issue 2-3, 2010, Pages 218-224

  de Filippi, Giovanna ^a   Mogg, Adrian J ^a   Phillips, Keith G ^a   Zwart, Ruud ^a   Sher, Emanuele ^b   Chen, Ying ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Dopamine neuron firing; GABA; Hippocampus; Nicotinic acetylcholine receptors; Noradrenaline release; Positive allosteric modulator; Ventral tegmental area

Indexed keywords

(2 AMINO 5 KETO)THIAZOLE; BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3BETA4; NICOTINIC RECEPTOR ALPHA4BETA2; NORADRENALIN; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; DRUG SELECTIVITY; GABAERGIC TRANSMISSION; HIPPOCAMPUS; MALE; NERVE CELL CULTURE; NEUROMODULATION; NEUROTRANSMISSION; NEWBORN; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

EID: 77955308216     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.064     Document Type: Article

References (36)

1. Albrecht B.K., Berry V., Boezio A.A., Cao L., Clarkin K., Guo W., Harmange J.C., Hierl M., Huang L., Janosky B., Knop J., Malmberg A., McDermott J.S., Nguyen H.Q., Springer S.K., Waldon D., Woodin K., McDonough S.I. Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant alpha4beta2 nicotinic acetylcholine receptor potentiators. Bioorg. Med. Chem. Lett. 2008, 18:5209-5212.
2. Albuquerque E.X., Pereira E.F., Alkondon M., Rogers S.W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 2009, 89:73-120.
3. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 1993, 265:1455-1473.
4. Alkondon M., Pereira E.F., Eisenberg H.M., Albuquerque E.X. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J. Neurosci. 1999, 19:2693-2705.
5. Barik J., Wonnacott S. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol. Pharmacol. 2006, 69:618-628.
6. Broad L.M., Zwart R., Pearson K.H., Lee M., Wallace L., McPhie G.I., Emkey R., Hollinshead S.P., Dell C.P., Baker S.R., Sher E. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators. J. Pharmacol. Exp. Ther. 2006, 318:1108-1117.
7. Champtiaux N., Gotti C., Cordero-Erausquin M., David D.J., Przybylski C., Lena C., Clementi F., Moretti M., Rossi F.M., Le Novere N., McIntosh J.M., Gardier A.M., Changeux J.P. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci. 2003, 23:7820-7829.
8. Chen Y., Sharples T.J., Phillips K.G., Benedetti G., Broad L.M., Zwart R., Sher E. The nicotinic alpha 4 beta 2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices. Neuropharmacology. 2003, 45:334-344.
9. Clarke P.B., Reuben M. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br. J. Pharmacol. 1996, 117:595-606.
10. Curtis L., Buisson B., Bertrand S., Bertrand D. Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol. Mol. Pharmacol. 2002, 61:127-135.
11. Dajas-Bailador F.A., Heimala K., Wonnacott S. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release. Mol. Pharmacol. 2003, 64:1217-1226.
12. Freedman R., Adams C.E., Leonard S. The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J. Chem. Neuroanat. 2000, 20:299-306.
13. Grace A.A., Onn S.P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J. Neurosci. 1989, 9:3463-3481.
14. Grady S.R., Moretti M., Zoli M., Marks M.J., Zanardi A., Pucci L., Clementi F., Gotti C. Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release. J. Neurosci. 2009, 29:2272-2282.
15. Grady S.R., Salminen O., Laverty D.C., Whiteaker P., McIntosh J.M., Collins A.C., Marks M.J. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem. Pharmacol. 2007, 74:1235-1246.
16. Hansen S.B., Taylor P. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors. J. Mol. Biol. 2007, 369:895-901.
17. Hosie A.M., Wilkins M.E., da Silva H.M., Smart T.G. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature. 2006, 444:486-489.
18. Hurst R.S., Hajos M., Raggenbass M., Wall T.M., Higdon N.R., Lawson J.A., Rutherford-Root K.L., Berkenpas M.B., Hoffmann W.E., Piotrowski D.W., Groppi V.E., Allaman G., Ogier R., Bertrand S., Bertrand D., Arneric S.P. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J. Neurosci. 2005, 25:4396-4405.
19. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 1992, 450:455-468.
20. Klink R., de Kerchove d'Exaerde A., Zoli M., Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 2001, 21:1452-1463.
21. Lammel S., Hetzel A., Hackel O., Jones I., Liss B., Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron. 2008, 57:760-773.
22. Luo S., Kulak J.M., Cartier G.E., Jacobsen R.B., Yoshikami D., Olivera B.M., McIntosh J.M. Alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 1998, 18:8571-8579.
23. Mansvelder H.D., McGehee D.S. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron. 2000, 27:349-357.
24. Margolis E.B., Lock H., Hjelmstad G.O., Fields H.L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?. J. Physiol. 2006, 577:907-924.
25. McClure-Begley T.D., King N.M., Collins A.C., Stitzel J.A., Wehner J.M., Butt C.M. Acetylcholine-stimulated [H-3] GABA release from mouse brain synaptosomes is modulated by alpha 4 beta 2 and alpha 4 alpha 5 beta 2 nicotinic receptor subtypes. Mol. Pharmacol. 2009, 75:918-926.
26. Ng H.J., Whittemore E.R., Tran M.B., Hogenkamp D.J., Broide R.S., Johnstone T.B., Zheng L., Stevens K.E., Gee K.W. Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators. Proc Natl. Acad. Sci. U. S. A. 2007, 104:8059-8064.
27. Perry E., Martin-Ruiz C., Lee M., Griffiths M., Johnson M., Piggott M., Haroutunian V., Buxbaum J.D., Nasland J., Davis K., Gotti C., Clementi F., Tzartos S., Cohen O., Soreq H., Jaros E., Perry R., Ballard C., McKeith I., Court J. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur. J. Pharmacol. 2000, 393:215-222.
28. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature. 1998, 391:173-177.
29. Sala F., Mulet J., Reddy K.P., Bernal J.A., Wikman P., Valor L.M., Peters L., Konig G.M., Criado M., Sala S. Potentiation of human alpha4beta2 neuronal nicotinic receptors by a Flustra foliacea metabolite. Neurosci. Lett. 2005, 373:144-149.
30. Springer S.K., Woodin K.S., Berry V., Boezio A.A., Cao L., Clarkin K., Harmange J.C., Hierl M., Knop J., Malmberg A.B., McDermott J.S., Nguyen H.Q., Waldon D., Albrecht B.K., McDonough S.I. Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptor. Bioorg. Med. Chem. Lett. 2008, 18:5643-5647.
31. Timmermann D.B., Gronlien J.H., Kohlhaas K.L., Nielsen E.O., Dam E., Jorgensen T.D., Ahring P.K., Peters D., Holst D., Chrsitensen J.K., Malysz J., Briggs C.A., Gopalakrishnan M., Olsen G.M. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J. Pharmacol. Exp. Ther. 2007, 323:294-307.
32. Vizi E.S., Kiss J.P. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 1998, 8:566-607.
33. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci. 2004, 5:483-494.
34. Yin R., French E.D. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study. Brain Res. Bull. 2000, 51:507-514.
35. Young G.T., Zwart R., Walker A.S., Sher E., Millar N.S. Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14686-14691.
36. Zoli M., Lena C., Picciotto M.R., Changeux J.P. Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J. Neurosci. 1998, 18:4461-4472.